Global Commission Presents Nuanced Approach for Defining Clinical Obesity

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 15, 2025.

By Elana Gotkine HealthDay Reporter

TUESDAY, Jan. 14, 2025 -- A global commission endorsed by 75 medical organizations around the world and published online Jan. 14 in The Lancet Diabetes & Endocrinology, presents a nuanced approach to defining clinical obesity as a chronic illness resulting from the effect of excess adiposity on organ and tissue function.

Francesco Rubino, M.D., from King's College London, and colleagues reviewed the available evidence and developed criteria for clinical obesity to aid clinical decision-making and prioritize therapeutic interventions.

The authors define obesity as a condition characterized by excess adiposity, with or without abnormal distribution or function of adipose tissue, and with causes that are multifactorial and incompletely understood. Clinical obesity can result in severe end-organ damage, causing life-altering and potentially life-threatening complications. Preclinical obesity is defined as a state of excess adiposity with preserved function of other tissues and organs and a varying risk for developing clinical obesity and several other noncommunicable diseases. Body mass index should be used as a surrogate measure of health risk at a population level, for epidemiological studies, or for screening purposes, rather than as an individual measure of health. The diagnosis of clinical obesity requires evidence of reduced organ or tissue function due to obesity or substantial, age-adjusted limitations of daily activities reflecting the specific effect of obesity on basic activities of daily living or both. Timely, evidence-based treatment should be provided to people with clinical obesity, with the aim of improving clinical manifestations of obesity and preventing end-organ damage.

"The question of whether obesity is a disease is flawed because it presumes an implausible all-or-nothing scenario where obesity is either always a disease or never a disease," Rubino said in a statement. "Evidence, however, shows a more nuanced reality."

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords